Article

Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma

2020-10-21

Abstract excerpt

<title>Abstract</title> <p><bold>Background:</bold> <italic>MYCN</italic> amplification is the most important genomic feature in neuroblastoma (NB). However, limited studies have been conducted on the <italic>MYCN</italic> non-amplified NB including low- and intermediate-risk NB. Here, the genomic characteristics of <italic>MYCN</italic> non-amplified NB were studied to allow for the identification of biomarkers...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: bc400037-9ecf-5515-9254-9b095bc6d1d3
DOI: 10.21203/rs.3.rs-26131/v4

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastomaDOI 10.21203/rs.3.rs-26131/v4Read

Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma.Semantic proximity Read

Identification of MYCN non-amplified neuroblastoma subgroups points towards molecular signatures for precision prognosis and therapy stratificationSemantic proximity Read

MYCN in Neuroblastoma: “Old Wine into New Wineskins”Semantic proximity Read

Molecular targeting therapies for neuroblastoma: Progress and challengesSemantic proximity Read

Clinically Relevant Cytotoxic Immune Cell Signatures and Clonal Expansion of T-Cell Receptors in High-Risk MYCN -Not-Amplified Human NeuroblastomaSemantic proximity Read

Whole exome sequencing of high-risk neuroblastoma identifies novel non-synonymous variants.Semantic proximity Read

The Neuroblastoma Microenvironment, Heterogeneity and Immunotherapeutic ApproachesSemantic proximity Read

The genetic landscape of high-risk neuroblastoma.Semantic proximity Read

Tumor Microenvironment in Neuroblastoma and Immunotherapeutic Approaches: Towards More Effective TreatmentSemantic proximity Read

International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology CommitteeSemantic proximity Read

Clinical evaluation of integrated panel testing by next-generation sequencing for somatic mutations in neuroblastomas with MYCN unamplification.Semantic proximity Read

The neuroblastoma tumor microenvironment: From an in-depth characterization towards novel therapiesSemantic proximity Read